Clifford Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Buy
504
+13
+3% +$13.3K 0.42% 35
2026
Q1
$452K Buy
491
+49
+11% +$49.7K 0.35% 45
2025
Q4
$475K Hold
442
0.37% 40
2025
Q3
$337K Hold
442
0.26% 57
2025
Q2
$345K Sell
442
-48
-10% -$37.3K 0.28% 52
2025
Q1
$405K Buy
490
+5
+1% +$4.16K 0.38% 44
2024
Q4
$374K Hold
485
0.29% 49
2024
Q3
$430K Hold
485
0.33% 51
2024
Q2
$439K Hold
485
0.35% 49
2024
Q1
$377K Hold
485
0.31% 51
2023
Q4
$283K Hold
485
0.26% 59
2023
Q3
$261K Hold
485
0.28% 59
2023
Q2
$227K Buy
+485
New +$203K 0.24% 67

Other funds holding LLY

Clifford Group's LLY Position: Q2 2026 in Review

Clifford Group increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $13.3K and bringing the position to 504 shares worth $605K. The position accounts for 0.42% of the portfolio, ranked #35.

Clifford Group first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clifford Group held 504 shares of Eli Lilly worth $605K as of Q2 2026.
  • Clifford Group bought 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.42% of Clifford Group's portfolio in Q2 2026, its #35 holding.
  • Clifford Group first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clifford Group's 13F filing for Q2 2026, filed 14 Aug 2026.